Defenses That Hold Up When Care Can't Stop

We start by understanding how your organization uses AI, whether that's ambient clinical documentation, prior authorization support, or a patient or member chatbot. We map what PHI each system can access, which clinical or coverage decisions it can influence, and what actions its agents can take on their own.

From there, we threat model the system, ideally before it reaches production, and test models, pipelines, agents, and connected EHR and claims integrations for prompt injection, data leakage, and excessive permissions. Each finding includes reproducible attack steps and remediation guidance, and retesting confirms that fixes and guardrails hold.

Our AI Security Program Assessment evaluates governance and program maturity across your AI portfolio and prioritizes improvements, giving security teams, leadership, and your board a clearer basis for decisions about AI risk.

Yes. We scope testing around the device, its environment, and your release milestones. Assessments can cover hardware, firmware, communication interfaces, and supporting software, including fuzz testing, with onsite testing when a device can't leave your facility. Findings and retesting results are documented to support your FDA premarket cybersecurity submission.

If a testing need comes up late in the release, we work with your team to scope it quickly and agree on priorities and timing, so you know what it means for your schedule.

Yes. We plan testing around your audit dates, enrollment periods, code freezes, and development schedules, leaving time for your team to address findings. We can share findings as testing progresses, so remediation starts before the final report. Developers get clear steps to reproduce each issue, and we coordinate retesting before your scheduled review, so reviewers can see what's been fixed and what still needs attention.

One national health insurer finished its annual testing earlier than in prior years, with no deadline extension, giving its teams more lead time before enrollment.

Each finding includes reproducible attack steps, its potential impact on PHI or clinical and claims systems, and practical remediation guidance, so your developers know what to fix first and how. Our testers work through findings with your team directly, including while testing is still underway.

Retesting confirms whether each fix holds. Findings can also inform new detections for your SOC, so your team can watch for attempts to exploit a weakness while the fix is in progress.

Our SOC documents what prompted each investigation, what analysts found, and why they took action, including any automation involved. Your team can use that record to show reviewers the reasoning behind a response decision.

A federal health claims contractor uses our Managed SOC as it prepares for its annual CMS security review, and its security team has singled out the quality of our investigation notes. We can also assess audit readiness and identify gaps in your supporting evidence before a request arrives.

Yes. Dedicated Defense embeds named UltraViolet practitioners within your team, using your tools and following your processes. Depending on your needs, support can include SOC operations, incident response, threat intelligence, application security, SIEM administration, and third-party risk.

Your leadership sets priorities. Our practitioners build knowledge of your environment over time and provide continuity in day-to-day work. At one global medical device manufacturer, embedded UltraViolet practitioners support functions from SOC operations to OT security, and each capability added in 2025 was operational within 30 days.